Search

Your search keyword '"Pantuck, Allan J."' showing total 417 results
Start Over Author "Pantuck, Allan J." Database Unpaywall
417 results on '"Pantuck, Allan J."'

3. INITIAL FINDINGS FROM THE MULTI-INSTITUTIONAL SARCOMATOID RENAL CELL CARCINOMA CONSORTIUM (SaRCC)

Author

Blum, Kyle A., primary, Mehr, Justin P., additional, Matin, Surena, additional, Karam, Jose A., additional, Pooli, Aydin, additional, Lebacle, Cedric, additional, Pantuck, Allan J., additional, Shuch, Brian, additional, Thompson, R. Houston, additional, Leibovich, Bradley, additional, Shah, Paras, additional, Hakimi, A. Ari, additional, and Russo, Paul, additional

Published
2024
Full Text
View/download PDF

6. Supplementary Figures 1-3. Supplmentary Tables 1-4. Supplementary Materials and Methods. from MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder Cancer

Author

Koutsioumpa, Marina, primary, Chen, Hsiao-Wang, primary, O'Brien, Neil, primary, Koinis, Filippos, primary, Mahurkar-Joshi, Swapna, primary, Vorvis, Christina, primary, Soroosh, Artin, primary, Luo, Tong, primary, Issakhanian, Shawnt, primary, Pantuck, Allan J., primary, Georgoulias, Vassilis, primary, Iliopoulos, Dimitrios, primary, Slamon, Dennis J., primary, and Drakaki, Alexandra, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Figures 1-3. Supplmentary Tables 1-4. Supplementary Materials and Methods. from MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder Cancer

Author

Koutsioumpa, Marina, primary, Chen, Hsiao-Wang, primary, O'Brien, Neil, primary, Koinis, Filippos, primary, Mahurkar-Joshi, Swapna, primary, Vorvis, Christina, primary, Soroosh, Artin, primary, Luo, Tong, primary, Issakhanian, Shawnt, primary, Pantuck, Allan J., primary, Georgoulias, Vassilis, primary, Iliopoulos, Dimitrios, primary, Slamon, Dennis J., primary, and Drakaki, Alexandra, primary

Published
2023
Full Text
View/download PDF

8. Data from MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder Cancer

Author

Koutsioumpa, Marina, primary, Chen, Hsiao-Wang, primary, O'Brien, Neil, primary, Koinis, Filippos, primary, Mahurkar-Joshi, Swapna, primary, Vorvis, Christina, primary, Soroosh, Artin, primary, Luo, Tong, primary, Issakhanian, Shawnt, primary, Pantuck, Allan J., primary, Georgoulias, Vassilis, primary, Iliopoulos, Dimitrios, primary, Slamon, Dennis J., primary, and Drakaki, Alexandra, primary

Published
2023
Full Text
View/download PDF

9. Data from MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder Cancer

Author

Koutsioumpa, Marina, primary, Chen, Hsiao-Wang, primary, O'Brien, Neil, primary, Koinis, Filippos, primary, Mahurkar-Joshi, Swapna, primary, Vorvis, Christina, primary, Soroosh, Artin, primary, Luo, Tong, primary, Issakhanian, Shawnt, primary, Pantuck, Allan J., primary, Georgoulias, Vassilis, primary, Iliopoulos, Dimitrios, primary, Slamon, Dennis J., primary, and Drakaki, Alexandra, primary

Published
2023
Full Text
View/download PDF

10. LBA03-01 89 Zr-DFO-GIRENTUXIMAB FOR PET/CT IMAGING OF INDETERMINATE RENAL MASSES–RESULTS FROM PHASE 3 ZIRCON STUDY

Author

Shuch, Brian, primary, Pantuck, Allan J., additional, Bernhard, Jean-Christophe, additional, Morris, Michael A., additional, Master, Viraj, additional, Scott, Andrew, additional, van Praet, Charles, additional, Bailly, Clement, additional, Önal, Bülent, additional, Aksoy, Tamer, additional, Merkx, Robin, additional, Schuster, David M., additional, Lee, Sze Ting, additional, Pandit-Taskar, Neeta, additional, Fan, Alice C., additional, Tauchmanova, Libuse, additional, Schmidt, Karl, additional, Vadali, Kavita, additional, Hayward, Colin, additional, and Mulders, Peter, additional

Published
2023
Full Text
View/download PDF

11. Data from A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer

Author

Aggarwal, Rahul R., primary, Schweizer, Michael T., primary, Nanus, David M., primary, Pantuck, Allan J., primary, Heath, Elisabeth I., primary, Campeau, Eric, primary, Attwell, Sarah, primary, Norek, Karen, primary, Snyder, Margo, primary, Bauman, Lisa, primary, Lakhotia, Sanjay, primary, Feng, Felix Y., primary, Small, Eric J., primary, Abida, Wassim, primary, and Alumkal, Joshi J., primary

Published
2023
Full Text
View/download PDF

12. Table S2 from Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis

Author

George, Daniel J., primary, Martini, Jean-Francois, primary, Staehler, Michael, primary, Motzer, Robert J., primary, Magheli, Ahmed, primary, Donskov, Frede, primary, Escudier, Bernard, primary, Li, Sherry, primary, Casey, Michelle, primary, Valota, Olga, primary, Laguerre, Brigitte, primary, Pantuck, Allan J., primary, Pandha, Hardev S., primary, Patel, Anup, primary, Lechuga, Maria, primary, and Ravaud, Alain, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Figure 2 from A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

Author

Sarker, Debashis, primary, Dawson, Nancy A., primary, Aparicio, Ana M., primary, Dorff, Tanya B., primary, Pantuck, Allan J., primary, Vaishampayan, Ulka N., primary, Henson, Lynn, primary, Vasist, Lakshmi, primary, Roy-Ghanta, Sumita, primary, Gorczyca, Michele, primary, York, Whitney, primary, Ganji, Gopinath, primary, Tolson, Jerry, primary, and de Bono, Johann S., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure 1 from A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

Author

Sarker, Debashis, primary, Dawson, Nancy A., primary, Aparicio, Ana M., primary, Dorff, Tanya B., primary, Pantuck, Allan J., primary, Vaishampayan, Ulka N., primary, Henson, Lynn, primary, Vasist, Lakshmi, primary, Roy-Ghanta, Sumita, primary, Gorczyca, Michele, primary, York, Whitney, primary, Ganji, Gopinath, primary, Tolson, Jerry, primary, and de Bono, Johann S., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table 1 from A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer

Author

Aggarwal, Rahul R., primary, Schweizer, Michael T., primary, Nanus, David M., primary, Pantuck, Allan J., primary, Heath, Elisabeth I., primary, Campeau, Eric, primary, Attwell, Sarah, primary, Norek, Karen, primary, Snyder, Margo, primary, Bauman, Lisa, primary, Lakhotia, Sanjay, primary, Feng, Felix Y., primary, Small, Eric J., primary, Abida, Wassim, primary, and Alumkal, Joshi J., primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure 3 from A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

Author

Sarker, Debashis, primary, Dawson, Nancy A., primary, Aparicio, Ana M., primary, Dorff, Tanya B., primary, Pantuck, Allan J., primary, Vaishampayan, Ulka N., primary, Henson, Lynn, primary, Vasist, Lakshmi, primary, Roy-Ghanta, Sumita, primary, Gorczyca, Michele, primary, York, Whitney, primary, Ganji, Gopinath, primary, Tolson, Jerry, primary, and de Bono, Johann S., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Table 2 from A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer

Author

Aggarwal, Rahul R., primary, Schweizer, Michael T., primary, Nanus, David M., primary, Pantuck, Allan J., primary, Heath, Elisabeth I., primary, Campeau, Eric, primary, Attwell, Sarah, primary, Norek, Karen, primary, Snyder, Margo, primary, Bauman, Lisa, primary, Lakhotia, Sanjay, primary, Feng, Felix Y., primary, Small, Eric J., primary, Abida, Wassim, primary, and Alumkal, Joshi J., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure 3 from A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

Author

Sarker, Debashis, primary, Dawson, Nancy A., primary, Aparicio, Ana M., primary, Dorff, Tanya B., primary, Pantuck, Allan J., primary, Vaishampayan, Ulka N., primary, Henson, Lynn, primary, Vasist, Lakshmi, primary, Roy-Ghanta, Sumita, primary, Gorczyca, Michele, primary, York, Whitney, primary, Ganji, Gopinath, primary, Tolson, Jerry, primary, and de Bono, Johann S., primary

Published
2023
Full Text
View/download PDF

19. Table S1 from Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis

Author

George, Daniel J., primary, Martini, Jean-Francois, primary, Staehler, Michael, primary, Motzer, Robert J., primary, Magheli, Ahmed, primary, Donskov, Frede, primary, Escudier, Bernard, primary, Li, Sherry, primary, Casey, Michelle, primary, Valota, Olga, primary, Laguerre, Brigitte, primary, Pantuck, Allan J., primary, Pandha, Hardev S., primary, Patel, Anup, primary, Lechuga, Maria, primary, and Ravaud, Alain, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figure 1 from A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer

Author

Aggarwal, Rahul R., primary, Schweizer, Michael T., primary, Nanus, David M., primary, Pantuck, Allan J., primary, Heath, Elisabeth I., primary, Campeau, Eric, primary, Attwell, Sarah, primary, Norek, Karen, primary, Snyder, Margo, primary, Bauman, Lisa, primary, Lakhotia, Sanjay, primary, Feng, Felix Y., primary, Small, Eric J., primary, Abida, Wassim, primary, and Alumkal, Joshi J., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure 2 from A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer

Author

Aggarwal, Rahul R., primary, Schweizer, Michael T., primary, Nanus, David M., primary, Pantuck, Allan J., primary, Heath, Elisabeth I., primary, Campeau, Eric, primary, Attwell, Sarah, primary, Norek, Karen, primary, Snyder, Margo, primary, Bauman, Lisa, primary, Lakhotia, Sanjay, primary, Feng, Felix Y., primary, Small, Eric J., primary, Abida, Wassim, primary, and Alumkal, Joshi J., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Table 2 from A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer

Author

Aggarwal, Rahul R., primary, Schweizer, Michael T., primary, Nanus, David M., primary, Pantuck, Allan J., primary, Heath, Elisabeth I., primary, Campeau, Eric, primary, Attwell, Sarah, primary, Norek, Karen, primary, Snyder, Margo, primary, Bauman, Lisa, primary, Lakhotia, Sanjay, primary, Feng, Felix Y., primary, Small, Eric J., primary, Abida, Wassim, primary, and Alumkal, Joshi J., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Table 1 from A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer

Author

Aggarwal, Rahul R., primary, Schweizer, Michael T., primary, Nanus, David M., primary, Pantuck, Allan J., primary, Heath, Elisabeth I., primary, Campeau, Eric, primary, Attwell, Sarah, primary, Norek, Karen, primary, Snyder, Margo, primary, Bauman, Lisa, primary, Lakhotia, Sanjay, primary, Feng, Felix Y., primary, Small, Eric J., primary, Abida, Wassim, primary, and Alumkal, Joshi J., primary

Published
2023
Full Text
View/download PDF

24. Table S4 from Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis

Author

George, Daniel J., primary, Martini, Jean-Francois, primary, Staehler, Michael, primary, Motzer, Robert J., primary, Magheli, Ahmed, primary, Donskov, Frede, primary, Escudier, Bernard, primary, Li, Sherry, primary, Casey, Michelle, primary, Valota, Olga, primary, Laguerre, Brigitte, primary, Pantuck, Allan J., primary, Pandha, Hardev S., primary, Patel, Anup, primary, Lechuga, Maria, primary, and Ravaud, Alain, primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figure 1 from A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer

Author

Aggarwal, Rahul R., primary, Schweizer, Michael T., primary, Nanus, David M., primary, Pantuck, Allan J., primary, Heath, Elisabeth I., primary, Campeau, Eric, primary, Attwell, Sarah, primary, Norek, Karen, primary, Snyder, Margo, primary, Bauman, Lisa, primary, Lakhotia, Sanjay, primary, Feng, Felix Y., primary, Small, Eric J., primary, Abida, Wassim, primary, and Alumkal, Joshi J., primary

Published
2023
Full Text
View/download PDF

26. Table S4 from Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis

Author

George, Daniel J., primary, Martini, Jean-Francois, primary, Staehler, Michael, primary, Motzer, Robert J., primary, Magheli, Ahmed, primary, Donskov, Frede, primary, Escudier, Bernard, primary, Li, Sherry, primary, Casey, Michelle, primary, Valota, Olga, primary, Laguerre, Brigitte, primary, Pantuck, Allan J., primary, Pandha, Hardev S., primary, Patel, Anup, primary, Lechuga, Maria, primary, and Ravaud, Alain, primary

Published
2023
Full Text
View/download PDF

27. Table S2 from Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis

Author

George, Daniel J., primary, Martini, Jean-Francois, primary, Staehler, Michael, primary, Motzer, Robert J., primary, Magheli, Ahmed, primary, Donskov, Frede, primary, Escudier, Bernard, primary, Li, Sherry, primary, Casey, Michelle, primary, Valota, Olga, primary, Laguerre, Brigitte, primary, Pantuck, Allan J., primary, Pandha, Hardev S., primary, Patel, Anup, primary, Lechuga, Maria, primary, and Ravaud, Alain, primary

Published
2023
Full Text
View/download PDF

28. Table S3 from Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis

Author

George, Daniel J., primary, Martini, Jean-Francois, primary, Staehler, Michael, primary, Motzer, Robert J., primary, Magheli, Ahmed, primary, Donskov, Frede, primary, Escudier, Bernard, primary, Li, Sherry, primary, Casey, Michelle, primary, Valota, Olga, primary, Laguerre, Brigitte, primary, Pantuck, Allan J., primary, Pandha, Hardev S., primary, Patel, Anup, primary, Lechuga, Maria, primary, and Ravaud, Alain, primary

Published
2023
Full Text
View/download PDF

29. Table S1 from Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis

Author

George, Daniel J., primary, Martini, Jean-Francois, primary, Staehler, Michael, primary, Motzer, Robert J., primary, Magheli, Ahmed, primary, Donskov, Frede, primary, Escudier, Bernard, primary, Li, Sherry, primary, Casey, Michelle, primary, Valota, Olga, primary, Laguerre, Brigitte, primary, Pantuck, Allan J., primary, Pandha, Hardev S., primary, Patel, Anup, primary, Lechuga, Maria, primary, and Ravaud, Alain, primary

Published
2023
Full Text
View/download PDF

30. Supplementary Figure 2 from A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer

Author

Aggarwal, Rahul R., primary, Schweizer, Michael T., primary, Nanus, David M., primary, Pantuck, Allan J., primary, Heath, Elisabeth I., primary, Campeau, Eric, primary, Attwell, Sarah, primary, Norek, Karen, primary, Snyder, Margo, primary, Bauman, Lisa, primary, Lakhotia, Sanjay, primary, Feng, Felix Y., primary, Small, Eric J., primary, Abida, Wassim, primary, and Alumkal, Joshi J., primary

Published
2023
Full Text
View/download PDF

31. Table S3 from Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis

Author

George, Daniel J., primary, Martini, Jean-Francois, primary, Staehler, Michael, primary, Motzer, Robert J., primary, Magheli, Ahmed, primary, Donskov, Frede, primary, Escudier, Bernard, primary, Li, Sherry, primary, Casey, Michelle, primary, Valota, Olga, primary, Laguerre, Brigitte, primary, Pantuck, Allan J., primary, Pandha, Hardev S., primary, Patel, Anup, primary, Lechuga, Maria, primary, and Ravaud, Alain, primary

Published
2023
Full Text
View/download PDF

32. Supplementary Figure 2 from A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

Author

Sarker, Debashis, primary, Dawson, Nancy A., primary, Aparicio, Ana M., primary, Dorff, Tanya B., primary, Pantuck, Allan J., primary, Vaishampayan, Ulka N., primary, Henson, Lynn, primary, Vasist, Lakshmi, primary, Roy-Ghanta, Sumita, primary, Gorczyca, Michele, primary, York, Whitney, primary, Ganji, Gopinath, primary, Tolson, Jerry, primary, and de Bono, Johann S., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure 1 from A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

Author

Sarker, Debashis, primary, Dawson, Nancy A., primary, Aparicio, Ana M., primary, Dorff, Tanya B., primary, Pantuck, Allan J., primary, Vaishampayan, Ulka N., primary, Henson, Lynn, primary, Vasist, Lakshmi, primary, Roy-Ghanta, Sumita, primary, Gorczyca, Michele, primary, York, Whitney, primary, Ganji, Gopinath, primary, Tolson, Jerry, primary, and de Bono, Johann S., primary

Published
2023
Full Text
View/download PDF

40. Results from phase 3 study of 89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma (ZIRCON).

Author

Shuch, Brian M., primary, Pantuck, Allan J., additional, Bernhard, Jean-Christophe, additional, Morris, Michael A., additional, Master, Viraj A., additional, Scott, Andrew Mark, additional, Van Praet, Charles, additional, Bailly, Clément, additional, Aksoy, Tamer, additional, Merkx, Robin, additional, Schuster, David M., additional, Lee, Sze Ting, additional, Pandit-Taskar, Neeta, additional, Fan, Alice C., additional, Tauchmanova, Libuse, additional, Allman, Phillip, additional, Vadali, Kavita, additional, Hayward, Colin, additional, and Mulders, Peter, additional

Published
2023
Full Text
View/download PDF

41. MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study

Author

Ehdaie, Behfar, primary, Tempany, Clare M, additional, Holland, Ford, additional, Sjoberg, Daniel D, additional, Kibel, Adam S, additional, Trinh, Quoc-Dien, additional, Durack, Jeremy C, additional, Akin, Oguz, additional, Vickers, Andrew J, additional, Scardino, Peter T, additional, Sperling, Dan, additional, Wong, Jeffrey Y C, additional, Yuh, Bertram, additional, Woodrum, David A, additional, Mynderse, Lance A, additional, Raman, Steven S, additional, Pantuck, Allan J, additional, Schiffman, Marc H, additional, McClure, Timothy D, additional, Sonn, Geoffrey A, additional, and Ghanouni, Pejman, additional

Published
2022
Full Text
View/download PDF

42. Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinoma

Author

Kroeger, Nils, primary, Lebacle, Cédric, additional, Hein, Justine, additional, Rao, P.N., additional, Nejati, Reza, additional, Wei, Shuanzeng, additional, Burchardt, Martin, additional, Drakaki, Alexandra, additional, Strother, Marshall, additional, Kutikov, Alexander, additional, Uzzo, Robert, additional, and Pantuck, Allan J., additional

Published
2022
Full Text
View/download PDF

45. MP46-03 PIVOTAL TRIAL OF MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION IN MEN WITH LOCALIZED PROSTATE CANCER: THREE-YEAR FOLLOW-UP

Author

Klotz, Laurence, primary, Pavlovich, Christian P., additional, Chin, Joseph, additional, Hatiboglu, Gencay, additional, Koch, Michael, additional, Penson, David, additional, Raman, Steven S., additional, Oto, Aytekin, additional, Fütterer, Jurgen, additional, Serrallach, Marc, additional, Relle, James, additional, Lotan, Yair, additional, Heidenreich, Axel, additional, Bonekamp, David, additional, Haider, Masoom A., additional, Sedelaar, JP Michiel, additional, Tirkes, Temel, additional, Arora, Sandeep S., additional, Macura, Katarzyna J., additional, Costa, Daniel N., additional, Pantuck, Allan J., additional, Bomers, Joyce, additional, Clarke, Gina, additional, Staruch, Robert, additional, and Eggener, Scott, additional

Published
2021
Full Text
View/download PDF

46. A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

Author

Sarker, Debashis, primary, Dawson, Nancy A., additional, Aparicio, Ana M., additional, Dorff, Tanya B., additional, Pantuck, Allan J., additional, Vaishampayan, Ulka N., additional, Henson, Lynn, additional, Vasist, Lakshmi, additional, Roy-Ghanta, Sumita, additional, Gorczyca, Michele, additional, York, Whitney, additional, Ganji, Gopinath, additional, Tolson, Jerry, additional, and de Bono, Johann S., additional

Published
2021
Full Text
View/download PDF

47. Reply by Authors

Author

Klotz, Laurence, primary, Pavlovich, Christian P., additional, Chin, Joseph, additional, Hatiboglu, Gencay, additional, Koch, Michael, additional, Penson, David, additional, Raman, Steven, additional, Oto, Aytekin, additional, Fütterer, Jurgen, additional, Serrallach, Marc, additional, Relle, James, additional, Lotan, Yair, additional, Heidenreich, Axel, additional, Bonekamp, David, additional, Haider, Masoom, additional, Tirkes, Temel, additional, Arora, Sandeep, additional, Macura, Katarzyna J., additional, Costa, Daniel N., additional, Persigehl, Thorsten, additional, Pantuck, Allan J., additional, Bomers, Joyce, additional, Burtnyk, Mathieu, additional, Staruch, Robert, additional, and Eggener, Scott, additional

Published
2021
Full Text
View/download PDF

48. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer

Author

Klotz, Laurence, primary, Pavlovich, Christian P., additional, Chin, Joseph, additional, Hatiboglu, Gencay, additional, Koch, Michael, additional, Penson, David, additional, Raman, Steven, additional, Oto, Aytekin, additional, Fütterer, Jurgen, additional, Serrallach, Marc, additional, Relle, James, additional, Lotan, Yair, additional, Heidenreich, Axel, additional, Bonekamp, David, additional, Haider, Masoom, additional, Tirkes, Temel, additional, Arora, Sandeep, additional, Macura, Katarzyna J., additional, Costa, Daniel N., additional, Persigehl, Thorsten, additional, Pantuck, Allan J., additional, Bomers, Joyce, additional, Burtnyk, Mathieu, additional, Staruch, Robert, additional, and Eggener, Scott, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results